IDH1 and central nervous system cancer: Classifying gliomas based on recurrent IDH1 point mutations, which have been linked to gliomagenesis (25, 26), is important because it distinguishes mutant IDH1 gliomas from wild-type-IDH1 (wt-IDH1) gliomas.